CLINICAL_TRIALS
trial_result
· 2017-01-10
Clinical Trial Update: Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma
Summary
A completed study assessed whether specific vitamin D receptor polymorphisms (ApaI and Tru9I) are linked to the risk of primary open-angle glaucoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lv Yingjuan | Conditions: Primary Open- Angle Glaucoma | Status: COMPLETED